Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects.

[1]  G. Zega,et al.  Toxic effects of two pesticides, Imazalil and Triadimefon, on the early development of the ascidian Phallusia mammillata (Chordata, Ascidiacea). , 2006, Aquatic toxicology.

[2]  G. Bernardini,et al.  Triadimefon Causes Branchial Arch Malformations in Xenopus laevis Embryos (5 pp) , 2006, Environmental science and pollution research international.

[3]  M. V. Van Allen,et al.  Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. , 2005, Birth defects research. Part A, Clinical and molecular teratology.

[4]  M. Maden,et al.  The control of morphogen signalling: regulation of the synthesis and catabolism of retinoic acid in the developing embryo. , 2005, Developmental biology.

[5]  V. Massa,et al.  Study on the common teratogenic pathway elicited by the fungicides triazole-derivatives. , 2005, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  R. Pennati,et al.  Teratogenic effects of two antifungal triazoles, triadimefon and triadimenol, on Xenopus laevis development: craniofacial defects. , 2005, Aquatic toxicology.

[7]  G. Tiboni,et al.  Murine Teratology of Fluconazole: Evaluation of Developmental Phase Specificity and Dose Dependence , 2005, Pediatric Research.

[8]  V. Massa,et al.  Craniofacial and axial skeletal defects induced by the fungicide triadimefon in the mouse. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.

[9]  S. Deresinski,et al.  Hepatotoxicity of antifungal agents. , 2005, Current opinion in investigational drugs.

[10]  L. Johnson,et al.  Second-generation azole antifungal agents. , 2005, Drugs of today.

[11]  C. di Ilio,et al.  Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole. , 2003, Toxicology letters.

[12]  J. Sobel,et al.  Antifungal drugs in pregnancy: a review , 2003, Expert opinion on drug safety.

[13]  P. Dollé,et al.  Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme expressed in the hindbrain, inner ear, first branchial arch and tooth buds during murine development. , 2003, Gene expression patterns : GEP.

[14]  D. Johnston,et al.  Interaction of all-trans-retinoic acid with fluconazole in acute promyelocytic leukemia. , 2003, Journal of pediatric hematology/oncology.

[15]  E. Menegola,et al.  Pathogenic pathways in fluconazole-induced branchial arch malformations. , 2003, Birth defects research. Part A, Clinical and molecular teratology.

[16]  J. Schlatter,et al.  Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase. , 2002, Environmental health perspectives.

[17]  Stephen W. Wilson,et al.  Distinct roles for Fgf, Wnt and retinoic acid in posteriorizing the neural ectoderm. , 2002, Development.

[18]  P. Chambon,et al.  Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis , 2002, Mechanisms of Development.

[19]  P. Chambon,et al.  Cloning of a novel retinoic-acid metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis with Cyp26A1 during early murine development , 2001, Mechanisms of Development.

[20]  E. Menegola,et al.  Antifungal triazoles induce malformations in vitro. , 2001, Reproductive toxicology.

[21]  J. Rossant,et al.  The retinoic acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic acid along the anterio-posterior axis within the mouse embryo. , 2001, Genes & development.

[22]  P. Chambon,et al.  The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral identity, and development of posterior structures. , 2001, Genes & development.

[23]  G. Koren,et al.  Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study. , 2000, American journal of obstetrics and gynecology.

[24]  Jay A. White,et al.  Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism. , 2000, Molecular endocrinology.

[25]  U. Dräger,et al.  Retinoids in embryonal development. , 2000, Physiological reviews.

[26]  P. Neuvonen,et al.  Effect of fluconazole on plasma fluvastatin and pravastatin concentrations , 2000, European Journal of Clinical Pharmacology.

[27]  M. Highland,et al.  Vitamin A deficiency results in the dose-dependent acquisition of anterior character and shortening of the caudal hindbrain of the rat embryo. , 2000, Developmental biology.

[28]  D. Frenz,et al.  Treatment with all-trans-retinoic acid decreases levels of endogenous TGF-beta(1) in the mesenchyme of the developing mouse inner ear. , 2000, Teratology.

[29]  René H. Levy,et al.  Metabolic Drug Interactions , 2000 .

[30]  E. Menegola,et al.  In vitro teratogenic potential of two antifungal triazoles: Triadimefon and triadimenol , 2000, In Vitro Cellular & Developmental Biology - Animal.

[31]  Chaya Kalcheim,et al.  The Neural Crest: Author Index , 1999 .

[32]  G. Koren,et al.  Reporting bias in retrospective ascertainment of drug-induced embryopathy , 1999, The Lancet.

[33]  M. Maden.  Heads or tails? Retinoic acid will decide. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[34]  H. Sørensen,et al.  Risk of malformations and other outcomes in children exposed to fluconazole in utero. , 1999, British journal of clinical pharmacology.

[35]  A. Durston,et al.  Expression of retinoic acid 4-hydroxylase (CYP26) during mouse and Xenopus laevis embryogenesis , 1999, Mechanisms of Development.

[36]  K. Kishi,et al.  Retinoid-induced limb defects 2: involvement of TGF-beta 2 in retinoid-induced inhibition of limb bud development. , 1999, Reproductive toxicology.

[37]  S. Jick.  Pregnancy Outcomes after Maternal Exposure to Fluconazole , 1999, Pharmacotherapy.

[38]  C. di Ilio,et al.  Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin. , 1999, Teratology.

[39]  J. Cleary,et al.  Antifungal therapy during pregnancy. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  P. Chambon,et al.  Mouse P450RAI (CYP26) Expression and Retinoic Acid-inducible Retinoic Acid Metabolism in F9 Cells Are Regulated by Retinoic Acid Receptor γ and Retinoid X Receptor α* , 1998, The Journal of Biological Chemistry.

[41]  J. Whiting,et al.  Craniofacial abnormalities induced by the ectopic expression of homeobox genes. , 1997, Mutation research.

[42]  D. Bartley,et al.  Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. , 1997, American journal of medical genetics.

[43]  W. Hurford,et al.  Fluconazole Serum Concentrations and Pharmacokinetics in an Obese Patient , 1997, Pharmacotherapy.

[44]  D. Gottlieb,et al.  CYP26, a Novel Mammalian Cytochrome P450, Is Induced by Retinoic Acid and Defines a New Family* , 1997, The Journal of Biological Chemistry.

[45]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[46]  D. Debruyne.  Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses , 1997, Clinical pharmacokinetics.

[47]  P. Mastroiacovo,et al.  Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. , 1996, American journal of obstetrics and gynecology.

[48]  W. Graninger,et al.  Fluconazole inCandida albicans sepsis during pregnancy: Case report and review of the literature , 1996, Infection.

[49]  L. Wienkers,et al.  Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[50]  Jouni Ahonen,et al.  The Effect of the Systemic Antimycotics, Itraconazole and Fluconazole, on the Pharmacokinetics and Pharmacodynamics of Intravenous and Oral Midazolam , 1996, Anesthesia and analgesia.

[51]  V. Prince,et al.  Late effects of retinoic acid on neural crest and aspects of rhombomere. , 1996, Development.

[52]  J. Abraham,et al.  Fluconazole-induced congenital anomalies in three infants. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  H. Saiga,et al.  Expression of the labial group Hox gene HrHox-1 and its alteration induced by retinoic acid in development of the ascidian Halocynthia roretzi. , 1995, Development.

[54]  S. Hallam,et al.  Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. , 1995, Biochemical pharmacology.

[55]  A. Rosemurgy,et al.  Bioavailability of fluconazole in surgical intensive care unit patients: a study comparing routes of administration. , 1995, The Journal of trauma.

[56]  P. Tam,et al.  Cranial paraxial mesoderm and neural crest cells of the mouse embryo: co-distribution in the craniofacial mesenchyme but distinct segregation in branchial arches. , 1995, Development.

[57]  A. Kulkarni,et al.  Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.

[58]  K. Machera.  Developmental toxicity of cyproconazole, an inhibitor of fungal ergosterol biosynthesis, in the rat , 1995, Bulletin of environmental contamination and toxicology.

[59]  Y. M. Lee,et al.  Retinoic acid stage-dependently alters the migration pattern and identity of hindbrain neural crest cells. , 1995, Development.

[60]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[61]  K. Eto,et al.  The contribution of both forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of mouse embryos. , 1994, Developmental biology.

[62]  Jackson A. Como,et al.  Oral azole drugs as systemic antifungal therapy. , 1994, The New England journal of medicine.

[63]  R. Krumlauf,et al.  Hox genes and pattern formation in the branchial region of the vertebrate head. , 1993, Trends in genetics : TIG.

[64]  G. Tiboni.  Second branchial arch anomalies induced by fluconazole, a bis-triazole antifungal agent, in cultured mouse embryos. , 1993, Research communications in chemical pathology and pharmacology.

[65]  R. Krumlauf,et al.  Retinoic acid alters hindbrain Hox code and induces transformation of rhombomeres 2/3 into a 4/5 identity , 1992, Nature.

[66]  A. R. Murthy,et al.  Congenital malformations in an infant born to a woman treated with fluconazole. , 1992, The Pediatric infectious disease journal.

[67]  P. Maloney,et al.  The molecular and cell biology of anion transport by bacteria , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.

[68]  S. Fraser,et al.  Vital dye analysis of cranial neural crest cell migration in the mouse embryo. , 1992, Development.

[69]  M. Kessel,et al.  Respecification of vertebral identities by retinoic acid. , 1992, Development.

[70]  K. Flanders,et al.  Interactions between retinoids and TGF beta s in mouse morphogenesis. , 1992, Development.

[71]  A. Graham,et al.  Segmental origin and migration of neural crest cells in the hindbrain region of the chick embryo. , 1991, Development.

[72]  Peter Gruss,et al.  Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid , 1991, Cell.

[73]  P. Murphy,et al.  Effects of retinoic acid excess on expression of Hox‐2.9 and Krox‐20 and on morphological segmentation in the hindbrain of mouse embryos. , 1991, The EMBO journal.

[74]  T. Jessell,et al.  Retinoic acid modifies the pattern of cell differentiation in the central nervous system of neurula stage Xenopus embryos. , 1991, Development.

[75]  Jerome J. Schentag,et al.  Effect of fluconazole on the disposition of phenytoin , 1991, Clinical pharmacology and therapeutics.

[76]  P. Vanparys,et al.  Safety aspects of oral antifungal agents. , 1990, British journal of clinical practice. Supplement.

[77]  H. Weintraub,et al.  Identification of a retinoic acid-sensitive period during primary axis formation in Xenopus laevis. , 1990, Genes & development.

[78]  M. Maden,et al.  Retinoic acid, a developmental signalling molecule , 1990, Trends in Neurosciences.

[79]  P. Vanparys,et al.  Toxicological Profile and Safety Evaluation of Antifungal Azole Derivatives , 1989, Mycoses.

[80]  H. Hendriks,et al.  Retinoic acid causes an anteroposterior transformation in the developing central nervous system , 1989, Nature.

[81]  R. Keynes,et al.  Segmental patterns of neuronal development in the chick hindbrain , 1989, Nature.

[82]  H. Lyr.  Modern Selective Fungicides , 1987 .

[83]  J. Massagué,et al.  Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. , 1987, The Journal of biological chemistry.

[84]  E. D. Kay.  Craniofacial dysmorphogenesis following hypervitaminosis A in mice. , 1987, Teratology.

[85]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[86]  P. Fernhoff,et al.  Retinoic acid embryopathy. , 1985, The New England journal of medicine.

[87]  J. Mason,et al.  Imidazole antimycotics: inhibitors of steroid aromatase. , 1985, Biochemical pharmacology.

[88]  J. Mason,et al.  Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[89]  D. Feldman,et al.  Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. , 1983, The Journal of clinical investigation.

[90]  R. Kahl,et al.  Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[91]  D. W. Weiss,et al.  Immunization against spontaneous and autografted mouse mammary carcinomas in the autochthonous C3H-Crgl mouse. , 1969, Cancer research.

[92]  J. Granits-Thurner,et al.  über die Wirkung von Zimtsäurederivaten auf hautpathogene Pilze , 1957 .

[93]  G. Bernardini,et al.  Gene expression in Xenopus laevis embryos after Triadimefon exposure. , 2007, Gene expression patterns : GEP.

[94]  D. Neubert,et al.  All-trans retinoic acid and 13-cis-retinoic acid in the rat whole-embryo culture: abnormal development due to the all-trans isomer , 2004, Archives of Toxicology.

[95]  M. Nahata,et al.  Pharmacokinetics of fluconazole after oral administration in children with human immunodeficiency virus infection , 2004, European Journal of Clinical Pharmacology.

[96]  W. Inman,et al.  Safety of fluconazole in the treatment of vaginal candidiasis , 2004, European Journal of Clinical Pharmacology.

[97]  V. Massa,et al.  Relationship between hindbrain segmentation, neural crest cell migration and branchial arch abnormalities in rat embryos exposed to fluconazole and retinoic acid in vitro. , 2004, Reproductive toxicology.

[98]  J. Schenkman,et al.  Roles of Cytochrome P450 in Development , 2001, Drug metabolism and drug interactions.

[99]  P. Chambon,et al.  Retinoic acid synthesis and hindbrain patterning in the mouse embryo. , 2000, Development.

[100]  P. Neuvonen,et al.  PHARMACOKINETICS AND DISPOSITION , 1998 .

[101]  G. Bennett,et al.  Altered gene expression in murine branchial arches following in utero exposure to retinoic acid. , 1995, Journal of craniofacial genetics and developmental biology.

[102]  M. Bronner‐Fraser.  Cell Interactions in Neural Crest Cell Migration , 1993 .

[103]  G. Morriss-Kay,et al.  Retinoic acid and development. , 1992, Pathobiology : journal of immunopathology, molecular and cellular biology.

[104]  R. Fromtling,et al.  Recent Trends in the Discovery, Development, and Evaluation of Antifungal Agents , 1987 .

[105]  H. Bossche.  Biochemical Targets for Antifungal Azole Derivatives: Hypothesis on the Mode of Action , 1985 .

[106]  D. Berg,et al.  Bifonazole, a biochemist's view. , 1984, Dermatologica.

[107]  D. Berg,et al.  Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behaviour of bifonazole. , 1984, Arzneimittel-Forschung.

[108]  G. Vettorazzi.  State of the art of the toxicological evaluation carried out by the joint FAO/WHO expert committee on pesticide residues. III. Miscellaneous pesticides used in agriculture and public health. , 1977, Residue reviews.